VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.
Currier MA; Eshun FK; Sholl A; Chernoguz A; Crawford K; Divanovic S; Boon L; Goins WF; Frischer JS; Collins MH; Leddon JL; Baird WH; Haseley A; Streby KA; Wang PY; Hendrickson BW; Brekken RA; Kaur B; Hildeman D; Cripe TP; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2013, vol. 21, issue 5, p 1014, ISSN 15250024. ISBN 15250024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef